Market Tracker

02/05 5:16pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

33.76
Delayed Data
As of Feb 05
 -1.14 / -3.27%
Today’s Change
31.83
Today|||52-Week Range
52.10
-21.05%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close34.90
Today’s open34.79
Day’s range33.52 - 35.13
Volume918,646
Average volume (3 months)809,288
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)-3.94%
Earnings growth (next 5 years)+24.96%
Revenue growth (last year)+16.53%
P/E ratio88.0
Price/Sales3.75
Price/Book2.71

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...-3.83-3.74%
MYGNMyriad Genetics Inc+0.04+0.11%
ACADACADIA Pharmaceutica...-0.93-4.58%
MDCOMedicines Co-1.86-5.66%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 22, 2016
EPS forecast (this quarter)$0.43
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts